肝炎E领域:挑战和机遇
Jia-Rui Li1, Ze Xiang1, Shu-Hui Li1
1School of Medicine, Zhejiang University, Hangzhou 310058, Zhejiang Province, China.
World journal of experimental medicine
|July 1, 2024
概括
肝炎E病毒 (HEV) 感染是一个全球性的健康问题,在免疫功能低下的人群中经常被诊断不足. 研究对于更好的诊断,更安全的治疗和了解HEV至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 传染性疾病 传染性疾病
背景情况:
- 肝炎E病毒 (HEV) 导致全球显著的发病率和死亡率,特别是在亚洲.
- 高血压病毒通过受污染的水和未煮熟的肉类传播,导致诊断不足,特别是在免疫受损的人群中.
- 现有的HEV治疗方法存在局限性和不良影响,突出显示需要更安全的替代方案.
研究的目的:
- 强调需要加强对肝炎E病毒的研究.
- 突出提高HEV诊断方法的重要性.
- 倡导开发更有效,更安全的HEV感染治疗方法.
主要方法:
- 关于HEV流行病学和当前治疗景观的文献综述.
- 分析HEV的肝外表现,包括神经和的影响.
- 综合当前的知识,以确定研究缺口和未来的方向.
主要成果:
- 在全球范围内,HEV影响了数十亿人,造成了相当大的死亡风险,特别是在亚洲.
- 诊断不足很普遍,特别是在免疫功能低下的患者群体中.
- 影响神经和系统的肝外表现需要进一步调查.
结论:
- 迫切需要加强HEV研究和改进诊断工具.
- 开发更安全,更有效的HEV治疗方法至关重要.
- 提高公众健康意识和预防措施对于控制HEV传播和影响至关重要.
相关概念视频
Diseases of the Liver and Gallbladder
2.4K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.4K
Esophageal Varices-II: Clinical Features and Management
811
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
811
Chronic Pancreatitis II: Collaborative Care
521
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
521
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
353
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
353
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
263
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
263
Hepatitis
59
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
59


